← Open Payments lookup

MARCO RABINES: Open Payments

NPI 1780833038 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,309 in 286 payments from 13 companies in 2025. Trend: 2023 $506 · 2024 $1,965 · 2025 $3,309

Food & beverage: $3,198Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.75$722
Neurocrine BioSciences, Inc.100$563
Janssen Pharmaceuticals, Inc32$439
ABBVIE INC.23$395
E.R. Squibb & Sons, L.L.C.21$336
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$210
Takeda Pharmaceuticals U.S.A., Inc.8$155
Vanda Pharmaceuticals Inc.2$137
Axsome Therapeutics, Inc.2$116
Alkermes, Inc.3$84

Products named: INGREZZA, INVEGA, VRAYLAR, COBENFY, UZEDY, AUSTEDO XR, CAPLYTA, TRINTELLIX.

Industry payments across FL — which companies pay providers there.